Eustasius Musenge to Anti-HIV Agents
This is a "connection" page, showing publications Eustasius Musenge has written about Anti-HIV Agents.
Connection Strength
1,659
-
Loss to Follow-Up Risk among HIV Patients on ART in Zimbabwe, 2009-2016: Hierarchical Bayesian Spatio-Temporal Modeling. Int J Environ Res Public Health. 2022 09 02; 19(17).
Score: 0,431
-
Markov modelling of viral load adjusting for CD4 orthogonal variable and multivariate conditional autoregressive mapping of the HIV immunological outcomes among ART patients in Zimbabwe. Theor Biol Med Model. 2021 08 21; 18(1):16.
Score: 0,401
-
Competing risk of mortality on loss to follow-up outcome among patients with HIV on ART: a retrospective cohort study from the Zimbabwe national ART programme. BMJ Open. 2020 10 06; 10(10):e036136.
Score: 0,377
-
The reliability of the modified lower extremity functional scale among adults living with HIV on antiretroviral therapy, in Rwanda, Africa. SAHARA J. 2014; 11:178-86.
Score: 0,236
-
Effectiveness of an Integrated Approach to HIV and Hypertension Care in Rural South Africa: Controlled Interrupted Time-Series Analysis. J Acquir Immune Defic Syndr. 2017 08 01; 75(4):472-479.
Score: 0,076
-
A cost-effective and focused model for HIV prevention. Lancet HIV. 2016 09; 3(9):e402-e403.
Score: 0,071
-
The effects of progressive-resisted exercises on muscle strength and health-related quality of life in persons with HIV-related poly-neuropathy in Zimbabwe. AIDS Care. 2016; 28(5):639-43.
Score: 0,068